Previous 10 | Next 10 |
Viatris Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference January 14, 2021 and Will Host its Inaugural Investor Day March 1, 2021 PITTSBURGH , Dec. 10, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will present at the J.P. Morgan 39 th ...
Healthcare stocks are a staple of every portfolio. With an ageing population, healthcare stocks are here to stay. We review our 6 favorite healthcare stocks. For further details see: Pfizer Vs. Merck Vs. AbbVie Vs. Bristol Myers Vs. Johnson & Johnson Vs. Amgen
My portfolio produced total returns of 11.2% in November. Year-to-date, I am up 17.95% through the first 11 months of the year. My passive income was up 26.61% in November. Year-to-date, my passive income is up 11.66%. For further details see: Nicholas Ward's Dividen...
Sesame Workshop and Viatris Inc. Launch Global Resources to Help Children and Caregivers Manage Social and Emotional Needs During Upcoming Holiday Season and Beyond NEW YORK , Dec. 7, 2020 /PRNewswire/ -- Ahead of a holiday season that will look dramatically differe...
This is the 8th update of our All Weather Dividends Portfolio. A lot of movement in the market has forced us to sell some of our positions. Yet, 10 stocks are still very attractively priced, although the gap might close soon. For further details see: All Weather Dividend...
Top five holdings add up to 50% of my portfolio. Portfolio currently yields approximately 3.91%. Lessons learned since my first review four years ago. For further details see: Eighth Review Of My Dividend Portfolio
We think there's an easy 20% upside on Viatris as it trades at a discount to pre-merger Mylan despite Upjohn delivering the margin products. It's a generics business with a great industrial base, but there are always going to be threats. Dividend will be ample and sustainable with...
Pfizer 's (NYSE: PFE) long-awaited deal is finally done. Last week, the big drugmaker completed its merger of Upjohn with Mylan. The transaction created a new entity, Viatris (NASDAQ: VTRS) , that's a leader in branded and generic drugs and biosimilars. If you owned Pfiz...
Viatris Inc. Announces FDA Tentative Approval of a Pediatric Formulation of Dolutegravir (DTG) Under PEPFAR Tentative approval will help enhance access to WHO-recommended pediatric medicine and reduce the cost of HIV treatment for children in low- and middle-income countries ...
The fund has managed to recover most of its losses after the COVID-19 pandemic related global market sell-off earlier this year. High-Dividend stocks might become an interesting asset class, once investors shift away their focus from stay-at-home economy. VYM has been successful s...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...